Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Jessica Weaver, PhD, MPH

Merck & Co., Inc.

Disclosure(s): Merck & Co., Inc.: Employee

Poster(s):

578 - Cost-effectiveness of Infant Vaccination with PCV15 Compared to PCV13 in the United States
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET
583 - Preferences and Attitudes of Healthcare Providers towards Pneumococcal Conjugate Vaccines (PCVs) for Children Ages Two and Under in the United States (US)
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET